Nurix Therapeutics (NRIX) Valuation Check After Recent Share Price Volatility And Rich Price To Sales Multiple [Yahoo! Finance]
Nurix Therapeutics, Inc. - Common stock (NRIX)
Company Research
Source: Yahoo! Finance
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Nurix Therapeutics (NRIX) has been drawing attention after recent share price swings, including a move of about 11% lower over the past month and roughly 10% lower over the past 3 months. See our latest analysis for Nurix Therapeutics. Those recent pullbacks fit into a mixed picture, with a 30 day share price return of 10.63% and a year to date share price return of an 11.57% decline, contrasting with a 1 year total shareholder return of 3.37% and a 3 year total shareholder return of 76.08%. This suggests long term holders have still seen meaningful gains even as shorter term momentum has cooled. If this kind of volatility has you looking wider across healthcare, it could be worth checking our screener of 27 healthcare AI stocks as a starting list of ideas. It is an easy way to see who else is working at the intersection of medicine and
Show less
Read more
Impact Snapshot
Event Time:
NRIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NRIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NRIX alerts
High impacting Nurix Therapeutics, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
NRIX
News
- Nurix Therapeutics (NRIX) Is Down 7.4% After Wider 2025 Losses And New ESOP Share Shelf - What's Changed [Yahoo! Finance]Yahoo! Finance
- Nurix Therapeutics, Inc. (NRIX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts [Yahoo! Finance]Yahoo! Finance
- Nurix Therapeutics (NASDAQ:NRIX) had its price target raised by analysts at Royal Bank Of Canada from $28.00 to $30.00. They now have an "outperform" rating on the stock.MarketBeat
- Nurix Therapeutics (NASDAQ:NRIX) was given a new $35.00 price target on by analysts at Stifel Nicolaus.MarketBeat
NRIX
Earnings
- 1/28/26 - Beat
NRIX
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 144
- 2/17/26 - Form SCHEDULE
- NRIX's page on the SEC website